Why McKesson (MCK) is a Top Growth Stock for the Long-Term

McKesson Corporation (MCK) is highlighted as a potential growth stock, holding a Zacks Rank #2 (Buy) and a VGM Score of A. The company's Growth Style Score is A, driven by a projected 12.6% year-over-year earnings growth for the current fiscal year, and a consensus earnings estimate increase of $0.63 to $37.21 per share for fiscal 2026 based on upward revisions by eight analysts.

Analysis

McKesson Corporation (MCK) is presented with strong growth indicators, holding a Zacks Rank #2 (Buy), a VGM Score of A, and a Growth Style Score of A. This positive assessment is underpinned by a forecasted year-over-year earnings growth of 12.6% for the current fiscal year. Further bolstering this outlook, eight analysts have revised their earnings estimates upwards for fiscal 2026 within the past 60 days, resulting in the Zacks Consensus Estimate for earnings per share increasing by $0.63 to $37.21. McKesson also demonstrates a consistent ability to outperform expectations, evidenced by an average earnings surprise of 3.9%. These metrics from the Zacks framework, which highlights that its top-rated stocks have historically outperformed the S&P 500, position MCK as a noteworthy healthcare services and information technology company with a favorable financial trajectory and strong analyst backing for continued growth.

Key Decisions for Investors

• Consider McKesson (MCK) for growth-oriented portfolios due to its strong Zacks Rank #2 (Buy), A-rated Growth and VGM scores, and positive earnings estimate revisions.
• Evaluate the potential for capital appreciation based on MCK's projected 12.6% current fiscal year earnings growth and the upwardly revised fiscal 2026 consensus EPS of $37.21.
• Monitor upcoming earnings releases and analyst sentiment to verify the continuation of its 3.9% average earnings surprise and sustained growth trajectory.